The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis
Rosalie A. Scholtes, Daniël H. van Raalte, Ricardo Correa-Rotter, Robert D. Toto, Hiddo J.L. Heerspink, Valerie Cain, C. David Sjöström, Peter Sartipy, Bergur V. Stefánsson
Dive into the research topics of 'The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis'. Together they form a unique fingerprint.